Defining the optimal selenium dose for prostate cancer risk reduction: Insights from the u-shaped relationship between selenium status, DNA damage, and apoptosis

Dose-Response

Volumn 8, Issue 3, 2010, Pages 285-300

  Chiang, Emily C ^a,b   Shen, Shuren ^a   Kengeri, Seema S ^a   Xu, Huiping ^c   Combs, Gerald F ^d   Morris, J Steven ^e   Bostwick, David G ^f   Waters, David J ^a,g  

^a Gerald P Murphy Cancer Foundation   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

^d GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^e UNIVERSITY OF MISSOURI   (United States)

^f BOSTWICK LABORATORIES   (United States)

^g PURDUE UNIVERSITY   (United States)

Author keywords

Cancer prevention; Dietary supplements; Dog; Non linear; Personalized medicine

Indexed keywords

EID: 78649409370     PISSN: None     EISSN: 15593258     Source Type: Journal    
DOI: 10.2203/dose-response.09-036.Chiang     Document Type: Article

References (73)

1. Allen NE, Appleby PN, Roddam AW, Tjønneland A, Johnsen NF, et al. 2008. Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 88:1567-1575.
2. Ames BN. 2006. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci U S A 103:17589-17594.
3. Bleys J, Navas-Acien A, and Guallar E. 2008. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med 168:404-410.
4. Cheng TP, Morris JS, Koirtyohann SR, Spate VL, and Baskett CK. 1994. The analysis of human nails for 24 elements via k0 and cyclic neutron activation analysis. Nuclear Instrum Methods Phys Res 353:457-460.
5. Clark LC, Combs GF Jr, Turnbull BW, Slate E, Chalker DK, et al. 1996. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276:1957-1963.
6. Clausen J, Nielsen SA, and Kristensen M. 1989. Biochemical and clinical effects of an antioxidant supplementation of geriatric patients: A double blind study. Biol Trace Elem Res 20:135-151.
7. Combs GF Jr, and Gray WP. 1998. Chemopreventive agents: selenium. Pharmacol Ther 79:179-192.
8. Cooper ML, Adami HO, Grönberg H, Wiklund F, Green FR, and Rayman MP. 2008. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate Cancer risk. Cancer Res 68:10171-10177.
9. Costello AJ. 2001. A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues. Urology 57:182-184.
10. Czernichow S, Couthouis A, Bertrais S, Vergnaud AC, Dauchet L, Galan P, et al. 2006. Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am J Clin Nutr 84:395-399.
11. Davis CD. 2007. Nutritional interactions: credentialing of molecular targets for cancer prevention. Exp Biol Med 232:176-183.
12. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, et al. 2002. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11:630-639.
13. Duthie SJ, and Collins AR. 1997. The influence of cell growth, detoxifying enzymes and DNA repair on hydrogen peroxide-mediated DNA damage (measured using the comet assay) in human cells. Free Radic Biol Med 22:717-724.
14. El-Bayoumy K. 2001. The protective role of selenium on genetic damage and on cancer. Mutat Res 475:123-139.
15. Facompre N and El-Bayoumy K. 2009. Potential stages for prostate cancer prevention with selenium: implications for cancer survivors. Cancer Res 69:2699-2703.
16. Fenech M. 2001. Recommended dietary allowances (RDAs) for genomic stability. Mutat Res 480-481:51-54.
17. Garland M, Morris JS, Rosner BA, Stampfer MJ, Spate VL, et al. 1993. Toenail trace element levels as biomarkers: reproducibility over a six year period. Cancer Epidemiol Biomarkers Prev 2:493-497.
18. Gavrieli Y, Sherman Y, and Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
19. Halliwell B. 2007. Oxidative stress and cancer: have we moved forward? Biochem J 401:1-11.
20. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, et al. 2000. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 92:2018-2023.
21. Hu H, Jiang C, Ip C, Rustum YM, and Lü J. 2005. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells. Clin Cancer Res 11:2379-2388.
22. Hu YJ, and Diamond AM. 2003. Role of glutathione peroxidase 1 in breast cancer: loss of heterozy-gosity and allelic differences in the response to selenium. Cancer Res 63:3347-3351.
23. Hunter DJ, Morris JS, Chute CG, Kushner E, Colditz GA, et al. 1990. Predictors of selenium concentration in human toenails. Am J Epidemiol 132:114-122.
24. Imai H, Suzuki T, Kashiwazaki H, Takemoto T, Izumi T, et al. 1990. Dietary habit and selenium concentrations in erythrocyte and serum in a group of middle-aged and elderly Japanese. Nutr Res 10:1205-1214.
25. Ip C, Thompson HJ, and Ganther HE. 2000. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. Cancer Epidemiol Biomarkers Prev 9:49-54.
26. Kafai MR, and Ganji V. 2003. Sex, age, geographical location, smoking, and alcohol consumption influence serum selenium concentrations in the USA: third National Health and Nutrition Examination Survey, 1988-1994. J Trace Elem Med Biol 17:13-18.
27. Karunasinghe N, Ryan J, Tuckey J, Masters J, Jamieson MJ, et al. 2004. DNA stability and serum selenium levels in a high-risk group for prostate cancer. Cancer Epidemiol Biomarkers Prev 13:391-397.
28. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, et al. 2001. SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial. J Urol 166:1311-1315.
29. Knekt P, Aromaa A, Maatela J, Alfthan G, Aaran RK, et al. 1990. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 82:864-868.
30. Kok FJ, de Bruijn AM, Hofman A, Vermeeren R, and Valkenburg HA. 1987. Is serum selenium a risk factor for cancer in men only? Am J Epidemiol 125:12-16.
31. Kornitzer M, Valente F, De Bacquer D, Neve J, and De Backer G. 2004. Serum selenium and cancer mortality: a nested case-control study within an age- and sex-stratified sample of the Belgian adult population. Eur J Clin Nutr 58:98-104.
32. Kumaraswamy E, Malykh A, Korotkov KV, Kozyavkin S, Hu Y, et al. 2000. Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology. J Biol Chem 275:35540-35547.
33. Li H, Kantoff PW, Giovannucci E, Leitzmann MF, Gaziano JM, et al. 2005. Manganese superoxide dis-mutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 65:2498-2504.
34. Li GX, Lee HJ, Wang Z, Hu H, Liao JD, et al. 2008. Superior in vivo inhibitory efficacy of methylse-leninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 29:1005-1012.
35. Li S, Zhou Y, Wang R, Zhang H, Dong Y, et al. 2007. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol Cancer Ther 6:1031-1038.
36. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, et al. 2009a. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301:39-51.
37. Lippman SM, Klein EA, and Goodman PJ. 2009b. Author reply. JAMA 301:1877.
38. Longnecker MP, Stampfer MJ, Morris JS, Spate VL, Baskett C, et al. 1993. A one year trial of the effect of high selenium bread on selenium levels in blood and toenails. Am J Clin Nutr 57:408-413.
39. Longnecker MP, Stram DO, Taylor PR, Levander OA, Howe M, et al. 1996. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology 7:384-390.
40. Lux O, and Naidoo D. 1995. The assessment of biological variation components of copper, zinc and selenium. J Nutr Biochem 6:43-47.
41. Mazzucchi S. 2007. Cancer-proof your body. Men's Health October 114-119.
42. McKown DM, and Morris JS. 1978. Rapid measurement of selenium in biological samples using instrumental neutron activation analysis. J Radioanal Chem 43:411-420.
43. Meltzer HM, Bibow K, Paulsen IT, Mundal H, Norheim G, and Holm H. 1993. Different bioavail-ability in humans of wheat and fish selenium as measured by blood platelet response to increased dietary Se. Biol Trace Elem Res 36:229-241.
44. Menter DG, Sabichi AL, and Lippman SM. 2000. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev 9:1171-1182.
45. Méplan C, Crosley LK, Nicol F, Beckett GJ, Howie AF, et al. 2007. Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J 21:3063-3074.
46. Morris JS, Willett WC, and Stampfer M. 1983. Toenails as an indicator of dietary selenium. Biol Trace Element Res 5:529-537.
47. Morris JS, Rohan T, Soskolne CL, Jain M, Horsman TL, et al. 2001. Selenium status and cancer mortality in subjects residing in four Canadian provinces. J Radioanal Nucl Chem 249:421-427.
48. Navarro-Alarcon M, De La Serrana HL, Perez-Valero V, and Lopez-Martinez C. 1998. Serum selenium levels as indicators of body status in cancer patients and their relationships with other nutritional and biochemical markers. Sci Total Environ 212:195-202.
49. Nève J. 2002. Selenium as a 'nutraceutical': how to conciliate physiological and supra-nutritional effects for an essential trace element. Curr Opin Clin Nutr Metab Care 5:659-663.
50. Patronek GJ, Waters DJ, and Glickman LT. 1997. Comparative longevity of pet dogs and humans: implications for gerontology research. J Gerontol A Biol Sci Med Sci 52:B171-B178.
51. Rayman MP. 2000. The importance of selenium to human health. Lancet 356:233-241.
52. Rayman MP. 2009. Selenoproteins and human health: insights from epidemiological data. Biochim Biophys Acta 1790:1533-1540.
53. Rayman MP, Combs GF Jr, and Waters DJ. 2009. Selenium and vitamin E supplementation for cancer prevention. JAMA 301:1876.
54. Samaha HS, Hamid R, el-Bayoumy K, Rao CV, and Reddy BS. 1997. The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Epidemiol Biomarkers Prev 6:699-704.
55. Seo YR, Kelley MR, and Smith ML. 2002. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci U SA 99:14548-14553.
56. Singh NP, McCoy MT, Tice RR, and Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191.
57. Southwest Oncology Group. 2008. SELECT participant letter. Available at www.cancer.gov/SELECT-participant-letter
58. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, et al. 2007. Effects of long-term selenium supplementation on the incidence of type 2 diabetes. Ann Intern Med 147:217-223.
59. Thomson CD, Robinson MF, Bulter JA, and Whanger PD. 1993. Long-term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC 1.11 1.9) in blood components of New Zealand women. Br J Nutr 69:577-588.
60. Thomson CD, and Robinson MF. 1996. The changing selenium status of New Zealand residents. Eur J Clin Nutr 50:107-114.
61. van den Brandt PA, Zeegers MP, Bode P, and Goldbohm RA. 2003. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 12:866-871.
62. Vinceti M, Rovesti S, Bergomi M, and Vivoli G. 2000. The epidemiology of selenium and human cancer. Tumori 86:105-118.
63. Vogt TM, Ziegler RG, Graubard BI, Swanson CA, Greenberg RS, et al. 2003. Serum selenium and risk of prostate cancer in U.S. blacks and whites. Int J Cancer 103:664-670.
64. Waters DJ, Shen S, Cooley DM, Bostwick DG, Qian J, et al. 2003. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J Natl Cancer Inst 95:237-241.
65. Waters DJ, Shen S, Glickman LT, Cooley DM, Bostwick DG, et al. 2005. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis 26:1256-1262.
66. Waters DJ, and Wildasin K. 2006. Cancer clues from pet dogs. Sci Am 295:94-101.
67. Waters DJ, Shen S, Xu H, Kengeri SS, Cooley DM, et al. 2007. Noninvasive prediction of prostatic DNA damage by oxidative stress challenge of peripheral blood lymphocytes. Cancer Epidemiol Biomarkers Prev 16:1906-1910.
68. Waters DJ, Chiang EC, and Bostwick DG. 2008. The art of casting nets: fishing for the prize of personalized cancer prevention. Nutr Cancer 60:1-6.
69. Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, et al. 2004. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke and total death. Am J Clin Nutr 79:80-85.
70. Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, et al. 1983. Prediagnostic serum selenium and risk of cancer. Lancet 2:130-134.
71. Wu J, Salisbury C, Graham R, Lyons G, Fenech M. 2009. Increased consumption of wheat bioforti-fied with selenium does not modify biomarkers of cancer risk, oxidative stress, or immune function in healthy Australian males. Environ Mol Mutagen 50:489-501.
72. Yoshizawa K, Willett WC, Morris JS, Stampfer MJ, Spiegelman D, et al. 1998. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 90:1219-1224.
73. Zeng H. 2009. Selenium as an essential micronutrient: roles in cell cycle and apoptosis. Molecules 14:1263-1278.